When this $6 offer was made, Moses was still a teenager. You have not been watching the market for a really long time.
The implanter market is not going away. It is the key part of chip making process. Now Axcelis has product not just in a sliver of that market called High energy, but in the most important part called High current. It must be just a matter of time before Axcelis will start its market recovery. I am starting to consider getting in.
It is clear that BHE is facing difficulties. Sales are down due to some strange and unexplained situation with their biggest telco customer. I don't believe that BHE just walked away from such customer. Secondly, because of drastically lower sales, the management is hinting at restructuring in the future. I expect that in Q2 they will announce a "one time" big charge for cutting capacity and restructuring to reflect move away from telco and computer businesses. This might go for two or more quarters. Expect much lower income in the next few quarters or even a loss. This stock looks like dead money at best. Likely a decisive drop back to $15 or lower level.
I hope that Kemet management and Loof in particular are focused mainly on running the company well. So far too much noise about some progressive mining of minerals in Africa, helping the poor and other such stuff while the company loses money and has flat sales.